Report Detail

Pharma & Healthcare Global Chorionic Gonadotropin for Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4655090
  • |
  • 05 December, 2025
  • |
  • Global
  • |
  • 80 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Chorionic Gonadotropin for Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Chorionic Gonadotropin for Injection is a medication that contains HCG and is used in fertility treatments and hormonal therapies.
This report is a detailed and comprehensive analysis for global Chorionic Gonadotropin for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chorionic Gonadotropin for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chorionic Gonadotropin for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chorionic Gonadotropin for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Chorionic Gonadotropin for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chorionic Gonadotropin for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chorionic Gonadotropin for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Chorionic Gonadotropin for Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
u-hCG
r-hCG
Market segment by Application
Hospital
Clinic
Others
Major players covered
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chorionic Gonadotropin for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chorionic Gonadotropin for Injection, with price, sales quantity, revenue, and global market share of Chorionic Gonadotropin for Injection from 2020 to 2025.
Chapter 3, the Chorionic Gonadotropin for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chorionic Gonadotropin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chorionic Gonadotropin for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chorionic Gonadotropin for Injection.
Chapter 14 and 15, to describe Chorionic Gonadotropin for Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Chorionic Gonadotropin for Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 u-hCG
    • 1.3.3 r-hCG
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Chorionic Gonadotropin for Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Chorionic Gonadotropin for Injection Market Size & Forecast
    • 1.5.1 Global Chorionic Gonadotropin for Injection Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Chorionic Gonadotropin for Injection Sales Quantity (2020-2031)
    • 1.5.3 Global Chorionic Gonadotropin for Injection Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Shanghai Livzon Pharmaceutical Co., Ltd.
    • 2.1.1 Shanghai Livzon Pharmaceutical Co., Ltd. Details
    • 2.1.2 Shanghai Livzon Pharmaceutical Co., Ltd. Major Business
    • 2.1.3 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product and Services
    • 2.1.4 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Shanghai Livzon Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd.
    • 2.2.1 Qingdao Guanlong Biopharmaceutical Co., Ltd. Details
    • 2.2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd. Major Business
    • 2.2.3 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product and Services
    • 2.2.4 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Qingdao Guanlong Biopharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
    • 2.3.1 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Details
    • 2.3.2 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Major Business
    • 2.3.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product and Services
    • 2.3.4 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Recent Developments/Updates
  • 2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd.
    • 2.4.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Details
    • 2.4.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Major Business
    • 2.4.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product and Services
    • 2.4.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Developments/Updates
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck Chorionic Gonadotropin for Injection Product and Services
    • 2.5.4 Merck Chorionic Gonadotropin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Merck Recent Developments/Updates

3 Competitive Environment: Chorionic Gonadotropin for Injection by Manufacturer

  • 3.1 Global Chorionic Gonadotropin for Injection Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Chorionic Gonadotropin for Injection Revenue by Manufacturer (2020-2025)
  • 3.3 Global Chorionic Gonadotropin for Injection Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Chorionic Gonadotropin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Chorionic Gonadotropin for Injection Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Chorionic Gonadotropin for Injection Manufacturer Market Share in 2024
  • 3.5 Chorionic Gonadotropin for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Chorionic Gonadotropin for Injection Market: Region Footprint
    • 3.5.2 Chorionic Gonadotropin for Injection Market: Company Product Type Footprint
    • 3.5.3 Chorionic Gonadotropin for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Chorionic Gonadotropin for Injection Market Size by Region
    • 4.1.1 Global Chorionic Gonadotropin for Injection Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Chorionic Gonadotropin for Injection Consumption Value by Region (2020-2031)
    • 4.1.3 Global Chorionic Gonadotropin for Injection Average Price by Region (2020-2031)
  • 4.2 North America Chorionic Gonadotropin for Injection Consumption Value (2020-2031)
  • 4.3 Europe Chorionic Gonadotropin for Injection Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Chorionic Gonadotropin for Injection Consumption Value (2020-2031)
  • 4.5 South America Chorionic Gonadotropin for Injection Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Chorionic Gonadotropin for Injection Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Chorionic Gonadotropin for Injection Sales Quantity by Type (2020-2031)
  • 5.2 Global Chorionic Gonadotropin for Injection Consumption Value by Type (2020-2031)
  • 5.3 Global Chorionic Gonadotropin for Injection Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Chorionic Gonadotropin for Injection Sales Quantity by Application (2020-2031)
  • 6.2 Global Chorionic Gonadotropin for Injection Consumption Value by Application (2020-2031)
  • 6.3 Global Chorionic Gonadotropin for Injection Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Chorionic Gonadotropin for Injection Sales Quantity by Type (2020-2031)
  • 7.2 North America Chorionic Gonadotropin for Injection Sales Quantity by Application (2020-2031)
  • 7.3 North America Chorionic Gonadotropin for Injection Market Size by Country
    • 7.3.1 North America Chorionic Gonadotropin for Injection Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Chorionic Gonadotropin for Injection Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Chorionic Gonadotropin for Injection Sales Quantity by Type (2020-2031)
  • 8.2 Europe Chorionic Gonadotropin for Injection Sales Quantity by Application (2020-2031)
  • 8.3 Europe Chorionic Gonadotropin for Injection Market Size by Country
    • 8.3.1 Europe Chorionic Gonadotropin for Injection Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Chorionic Gonadotropin for Injection Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Chorionic Gonadotropin for Injection Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Chorionic Gonadotropin for Injection Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Chorionic Gonadotropin for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Chorionic Gonadotropin for Injection Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Chorionic Gonadotropin for Injection Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Chorionic Gonadotropin for Injection Sales Quantity by Type (2020-2031)
  • 10.2 South America Chorionic Gonadotropin for Injection Sales Quantity by Application (2020-2031)
  • 10.3 South America Chorionic Gonadotropin for Injection Market Size by Country
    • 10.3.1 South America Chorionic Gonadotropin for Injection Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Chorionic Gonadotropin for Injection Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Chorionic Gonadotropin for Injection Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Chorionic Gonadotropin for Injection Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Chorionic Gonadotropin for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Chorionic Gonadotropin for Injection Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Chorionic Gonadotropin for Injection Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Chorionic Gonadotropin for Injection Market Drivers
  • 12.2 Chorionic Gonadotropin for Injection Market Restraints
  • 12.3 Chorionic Gonadotropin for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Chorionic Gonadotropin for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Chorionic Gonadotropin for Injection
  • 13.3 Chorionic Gonadotropin for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Chorionic Gonadotropin for Injection Typical Distributors
  • 14.3 Chorionic Gonadotropin for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Chorionic Gonadotropin for Injection. Industry analysis & Market Report on Chorionic Gonadotropin for Injection is a syndicated market report, published as Global Chorionic Gonadotropin for Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Chorionic Gonadotropin for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report